Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elena Colombo

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
JCO Precision Oncology|July 24, 2023
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient CareAndrea Vingiani, Luca Agnelli, Matteo Duca, et al.
Frontiers in Public Health|November 7, 2025
Exposome, oxidative stress and inflammation in persons with multiple sclerosis: the EXPOSITION study protocolMaria Cristina Monti, Rachele De Giuseppe, Gloria Bertoli, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 21, 2025
Conformational Antibodies to Proteolipid Protein-1 and Its Peripheral Isoform DM20 in Patients With CNS Autoimmune Demyelinating DisordersStefano Masciocchi, Pietro Businaro, Giacomo Greco, et al.
Journal of Neurology|March 10, 2026
HerMeS: a registry-based evaluation of the HERCULES criteria for identifying nonrelapsing SPMSTommaso Guerra, Giuseppe Lucisano, Maria A Rocca, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 17, 2025
Conformational Antibodies to Proteolipid Protein-1 and Its Peripheral Isoform DM20 in Patients With CNS Autoimmune Demyelinating DisordersStefano Masciocchi, Pietro Businaro, Giacomo Greco, et al.
JAMA Neurology|June 2, 2025
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated SyndromeNicolás Fissolo, Sabine Schaedelin, Luisa M Villar, et al.
JAMA Network Open|November 3, 2025
Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MSShalom Haggiag, Luca Prosperini, Massimo Filippi, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
JCO Precision Oncology|July 24, 2023
Molecular Tumor Board as a Clinical Tool for Converting Molecular Data Into Real-World Patient CareAndrea Vingiani, Luca Agnelli, Matteo Duca, et al.
Frontiers in Public Health|November 7, 2025
Exposome, oxidative stress and inflammation in persons with multiple sclerosis: the EXPOSITION study protocolMaria Cristina Monti, Rachele De Giuseppe, Gloria Bertoli, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|March 21, 2025
Conformational Antibodies to Proteolipid Protein-1 and Its Peripheral Isoform DM20 in Patients With CNS Autoimmune Demyelinating DisordersStefano Masciocchi, Pietro Businaro, Giacomo Greco, et al.
Journal of Neurology|March 10, 2026
HerMeS: a registry-based evaluation of the HERCULES criteria for identifying nonrelapsing SPMSTommaso Guerra, Giuseppe Lucisano, Maria A Rocca, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 17, 2025
Conformational Antibodies to Proteolipid Protein-1 and Its Peripheral Isoform DM20 in Patients With CNS Autoimmune Demyelinating DisordersStefano Masciocchi, Pietro Businaro, Giacomo Greco, et al.
JAMA Neurology|June 2, 2025
Prognostic Factors for Multiple Sclerosis Symptoms in Radiologically Isolated SyndromeNicolás Fissolo, Sabine Schaedelin, Luisa M Villar, et al.
JAMA Network Open|November 3, 2025
Comparative Effectiveness of Cladribine and S1P Receptor Modulators in Treatment-Naive Relapsing-Remitting MSShalom Haggiag, Luca Prosperini, Massimo Filippi, et al.
Pageof 9